• Je něco špatně v tomto záznamu ?

Eligibility for mechanical thrombectomy in acute ischemic stroke: A phase IV multi-center screening log registry

G. Tsivgoulis, N. Goyal, R. Mikulik, VK. Sharma, AH. Katsanos, R. Zand, PR. Paliwal, A. Roussopoulou, O. Volny, A. Pandhi, C. Zompola, L. Elijovich, A. Safouris, J. Chang, AV. Alexandrov, AW. Alexandrov,

. 2016 ; 371 (-) : 96-99. [pub] 20161012

Jazyk angličtina Země Nizozemsko

Typ dokumentu klinické zkoušky, fáze IV, časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023485

No eligibility screening logs were kept in recent mechanical thrombectomy (MT) RCTs establishing safety and efficacy of endovascular reperfusion therapies for acute ischemic stroke (AIS). We sought to evaluate the potential eligibility for MT among consecutive AIS patients in a prospective international multicenter study. We prospectively evaluated consecutive AIS patients admitted in four tertiary-care stroke centers during a twelve-month period. Potential eligibility for MT was evaluated using inclusion criteria from MR CLEAN & REVASCAT. Our study population consisted of 1464 AIS patients (mean age 67±14years, 56% men, median admission NIHSS-score: 5, IQR: 3-10). A total of 123 (8%, 95% CI: 7%-10%) and 82 (6%, 95% CI: 5%-7%) patients fulfilled the inclusion criteria for MR CLEAN&REVASCAT respectively. No evidence of heterogeneity (p>0.100) was found in the eligibility for MT across the participating centers. Absence of proximal intracranial occlusion (69%) and hospital arrival outside the eligible time window (38% for MR CLEAN & 35% for REVASCAT) were the two most common reasons for ineligibility for MT. Our everyday clinical practice experience suggests that approximately one out of thirteen to seventeen consecutive AIS may be eligible for MT if inclusion criteria for MR CLEAN and REVASCAT are strictly adhered to.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023485
003      
CZ-PrNML
005      
20170906114541.0
007      
ta
008      
170720s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jns.2016.10.018 $2 doi
035    __
$a (PubMed)27871458
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Tsivgoulis, Georgios $u Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, United States; Second Department of Neurology, "Attikon University Hospital", School of Medicine, University of Athens, Athens, Greece; International Clinical Research Center, St. Anne's Hospital, Brno, Czech Republic. Electronic address: tsivgoulisgiorg@yahoo.gr.
245    10
$a Eligibility for mechanical thrombectomy in acute ischemic stroke: A phase IV multi-center screening log registry / $c G. Tsivgoulis, N. Goyal, R. Mikulik, VK. Sharma, AH. Katsanos, R. Zand, PR. Paliwal, A. Roussopoulou, O. Volny, A. Pandhi, C. Zompola, L. Elijovich, A. Safouris, J. Chang, AV. Alexandrov, AW. Alexandrov,
520    9_
$a No eligibility screening logs were kept in recent mechanical thrombectomy (MT) RCTs establishing safety and efficacy of endovascular reperfusion therapies for acute ischemic stroke (AIS). We sought to evaluate the potential eligibility for MT among consecutive AIS patients in a prospective international multicenter study. We prospectively evaluated consecutive AIS patients admitted in four tertiary-care stroke centers during a twelve-month period. Potential eligibility for MT was evaluated using inclusion criteria from MR CLEAN & REVASCAT. Our study population consisted of 1464 AIS patients (mean age 67±14years, 56% men, median admission NIHSS-score: 5, IQR: 3-10). A total of 123 (8%, 95% CI: 7%-10%) and 82 (6%, 95% CI: 5%-7%) patients fulfilled the inclusion criteria for MR CLEAN&REVASCAT respectively. No evidence of heterogeneity (p>0.100) was found in the eligibility for MT across the participating centers. Absence of proximal intracranial occlusion (69%) and hospital arrival outside the eligible time window (38% for MR CLEAN & 35% for REVASCAT) were the two most common reasons for ineligibility for MT. Our everyday clinical practice experience suggests that approximately one out of thirteen to seventeen consecutive AIS may be eligible for MT if inclusion criteria for MR CLEAN and REVASCAT are strictly adhered to.
650    _2
$a senioři $7 D000368
650    _2
$a ischemie mozku $x terapie $7 D002545
650    _2
$a dokumentace $7 D004282
650    12
$a určení vhodnosti pacienta $7 D004608
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a dodržování směrnic $7 D019983
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a mechanická trombolýza $7 D061185
650    _2
$a randomizované kontrolované studie jako téma $7 D016032
650    _2
$a registrace $7 D012042
650    _2
$a cévní mozková příhoda $x terapie $7 D020521
650    _2
$a centra terciární péče $7 D062606
650    _2
$a čas zasáhnout při rozvinutí nemoci $7 D061665
655    _2
$a klinické zkoušky, fáze IV $7 D017429
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Goyal, Nitin $u Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, United States.
700    1_
$a Mikulik, Robert $u International Clinical Research Center, St. Anne's Hospital, Brno, Czech Republic; First Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Sharma, Vijay K $u Division of Neurology, National University Hospital System, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
700    1_
$a Katsanos, Aristeidis H $u Second Department of Neurology, "Attikon University Hospital", School of Medicine, University of Athens, Athens, Greece.
700    1_
$a Zand, Ramin $u Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, United States.
700    1_
$a Paliwal, Prakash R $u Division of Neurology, National University Hospital System, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
700    1_
$a Roussopoulou, Andromachi $u Second Department of Neurology, "Attikon University Hospital", School of Medicine, University of Athens, Athens, Greece.
700    1_
$a Volny, Ondrej $u International Clinical Research Center, St. Anne's Hospital, Brno, Czech Republic; First Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Pandhi, Abhi $u Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, United States.
700    1_
$a Zompola, Christina $u Second Department of Neurology, "Attikon University Hospital", School of Medicine, University of Athens, Athens, Greece.
700    1_
$a Elijovich, Lucas $u Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, United States; Department of Neurosurgery, University of Tennessee Health Science Center, Memphis, TN, United States.
700    1_
$a Safouris, Apostolos $u Second Department of Neurology, "Attikon University Hospital", School of Medicine, University of Athens, Athens, Greece; Acute Stroke Unit, Metropolitan Hospital, Piraeus, Greece.
700    1_
$a Chang, Jason $u Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, United States.
700    1_
$a Alexandrov, Andrei V $u Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, United States. $7 gn_A_00003944
700    1_
$a Alexandrov, Anne W $u Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, United States; Australian Catholic University, Sydney, Australia. $7 gn_A_00003945
773    0_
$w MED00003004 $t Journal of the neurological sciences $x 1878-5883 $g Roč. 371, č. - (2016), s. 96-99
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27871458 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170906115139 $b ABA008
999    __
$a ok $b bmc $g 1239166 $s 984398
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 371 $c - $d 96-99 $e 20161012 $i 1878-5883 $m Journal of the neurological sciences $n J Neurol Sci $x MED00003004
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace